Page last updated: 2024-09-05

zm 241385 and Central Nervous System Diseases

zm 241385 has been researched along with Central Nervous System Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cunha, RA; Dall'Igna, OP; Dall'lgna, OP; Lara, DR; Porciúncula, LO; Souza, DO	1

Other Studies

1 other study(ies) available for zm 241385 and Central Nervous System Diseases

Article	Year
Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. British journal of pharmacology, 2003, Volume: 138, Issue:7 Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Caffeine; Cells, Cultured; Central Nervous System Diseases; Cerebellum; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Wistar; Receptor, Adenosine A2A; Theophylline; Triazines; Triazoles	2003

Article

Year

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity.

British journal of pharmacology, 2003, Volume: 138, Issue:7

Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Caffeine; Cells, Cultured; Central Nervous System Diseases; Cerebellum; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Wistar; Receptor, Adenosine A2A; Theophylline; Triazines; Triazoles

2003